Trial Profile
A randomized, open label, multi-center clinical trial, comparing microbiologic response to linezolid and vancomycin in ventilator-associated pneumonia (VAP) due to methicillin resistant Staphylococcus aureus (MRSA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jun 2010
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary) ; Vancomycin
- Indications Methicillin-resistant Staphylococcus aureus infections; Ventilator associated pneumonia
- Focus Therapeutic Use
- Sponsors Pfizer
- 08 Jun 2010 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 03 Jan 2008 New trial record.